Gossamer Bio Inc. (GOSS)
NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
GOSS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $62.26M
- EPS (TTM)
- -$52.80
- Dividend yield
- None
- 52-week range
- 9.12 – 309.60
- Day range
- 9.77 – 10.66
- Volume / Avg
- 280.27K / 376.09K
- Beta
- —
- Shares outstanding
- 6.12M
- Next earnings
- Nov 4, 2026
52-week range
GOSS stock today
Shares of Gossamer Bio (GOSS) finished lower on Oct 7 at $10.18, a drop of 5.57% or $0.60 per share, versus the S&P 500's 0.22% decline. At this level, GOSS sits near the bottom of its 52-week range of $9.12 to $309.60: 96.7% below the high, set on Dec 15, 2025 and 11.6% above the low. GOSS is down 95.9% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 94.9%.
Gossamer Bio has posted a net loss over the last twelve months (EPS of -$52.80), so its P/E ratio is not meaningful. Gossamer Bio's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Gossamer Bio
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2019
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-5.55
Gossamer Bio peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| APLMApollomics Inc. Class A | 21.50 | -2.71% | $62.67M | vs GOSS |
| RNXTRenovoRx Inc. | 1.37 | -1.44% | $61.83M | vs GOSS |
| PLRXPliant Therapeutics Inc. | 0.99 | -3.88% | $61.30M | vs GOSS |
| ATHEAlterity Therapeutics Limited ADR | 3.32 | -1.48% | $60.45M | vs GOSS |
| BOLDBoundless Bio Inc. | 2.64 | +2.72% | $60.05M | vs GOSS |
| IBIOiBio Inc. | 1.01 | -3.81% | $64.95M | vs GOSS |
| CNTBConnect Biopharma Holdings Limited | 0.9447 | +4.34% | $59.49M | vs GOSS |
| XLOXilio Therapeutics Inc. | 9.01 | +0.11% | $59.29M | vs GOSS |
Indexes, lists and sector
Gossamer Bio stock FAQ
What is Gossamer Bio's stock price today?
GOSS last traded at $10.18 as of Oct 7, 4:00 PM EDT, down 5.57% on the day. Prices are delayed at least 15 minutes.
Does Gossamer Bio pay a dividend?
No. Gossamer Bio does not currently pay a regular cash dividend.
When is Gossamer Bio's next earnings date?
Gossamer Bio is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-5.55.
Has GOSS ever split its stock?
Yes. The most recent GOSS stock split was a 1-for-80 split on Sep 11, 2026.
What is the GOSS 52-week high?
The 52-week high for GOSS is $309.60 and the 52-week low is $9.12. The stock is currently 96.7% below its high.